Priority Date: 03.07.12 (EP 20120174797)

PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}METHYL)-2-THIOPHENECARBOXAMIDE

  • Application ID: EP13735235
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Applicant

Technology company logo small
Technology Company

Attorney

Technology company logo thumb
no operation time available
3 offices
Technology Company

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 03.07.2012 - Priority Date (EP 20120174797)
  • 09.01.2014 - Publication A1 (WO2014005934)
  • 13.05.2015 - Publication A1 (EP2869814)
  • 06.04.2016 - Publication B1 (EP2869814)

IPC Classification